40 studies found for:    Open Studies | "Testicular Diseases"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Testicular Diseases"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  The Incidence of Congenital Undescended Testis Among Dutch Infants
Condition: Undescended Testis
Intervention:
2 Unknown  Effect of Environmental Exposures on the Egg Fertilizing Ability of Human Sperm
Conditions: Male Infertility;   Testicular Diseases;   Urologic and Male Genital Diseases;   Lead Poisoning
Intervention:
3 Not yet recruiting Visual Guidelines and Tutoring in Pediatric Urological Surgery
Conditions: Hypospadias;   Undescended Testis;   Hydrocele;   Ureteropelvic Junction Stenosis;   Anxiety
Interventions: Behavioral: Picture book;   Behavioral: Standard preoperative education
4 Recruiting Autologous Dendritic Cell Vaccine Loaded With Allogeneic Tumor Lysate Expression of Cancer Testis Antigens in Patients With Soft Tissue Sarcoma
Conditions: Sarcoma;   Neoplasms, Connective and Soft Tissue
Intervention: Biological: Autologous dendritic cell vaccine
5 Recruiting Trial of 1 Cycle of Adjuvant BEP Chemotherapy in High Risk, Stage 1 Non-seminomatous Germ Cell Testis Tumours
Condition: Stage I Testicular Non-Seminomatous Germ Cell Tumor
Intervention: Drug: BEP(500)
6 Recruiting High-dose Chemotherapy for Poor-prognosis Relapsed Germ-Cell Tumors
Condition: Testicular Cancer
Interventions: Drug: Bevacizumab;   Drug: Gemcitabine;   Drug: Docetaxel;   Drug: Melphalan;   Drug: Carboplatin;   Drug: Mesna;   Drug: Ifosfamide;   Drug: Etoposide;   Procedure: Stem Cell Transplant
7 Recruiting Magnetic Resonance Imaging and Computed Tomography in Patients With Stage I Seminoma of the Testicle
Condition: Testicular Germ Cell Tumor
Interventions: Other: questionnaire administration;   Procedure: computed tomography;   Procedure: magnetic resonance imaging;   Procedure: quality-of-life assessment
8 Recruiting Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant
Conditions: Childhood Acute Lymphoblastic Leukemia in Remission;   Childhood Acute Myeloid Leukemia in Remission;   Childhood Chronic Myelogenous Leukemia;   Childhood Myelodysplastic Syndromes;   Chronic Eosinophilic Leukemia;   Chronic Myelomonocytic Leukemia;   Chronic Neutrophilic Leukemia;   de Novo Myelodysplastic Syndromes;   Disseminated Neuroblastoma;   Juvenile Myelomonocytic Leukemia;   Mucositis;   Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable;   Previously Treated Childhood Rhabdomyosarcoma;   Previously Treated Myelodysplastic Syndromes;   Recurrent Childhood Acute Lymphoblastic Leukemia;   Recurrent Childhood Acute Myeloid Leukemia;   Recurrent Childhood Large Cell Lymphoma;   Recurrent Childhood Lymphoblastic Lymphoma;   Recurrent Childhood Rhabdomyosarcoma;   Recurrent Childhood Small Noncleaved Cell Lymphoma;   Recurrent Malignant Testicular Germ Cell Tumor;   Recurrent Wilms Tumor and Other Childhood Kidney Tumors;   Recurrent/Refractory Childhood Hodgkin Lymphoma;   Relapsing Chronic Myelogenous Leukemia;   Secondary Acute Myeloid Leukemia;   Secondary Myelodysplastic Syndromes;   Unspecified Childhood Solid Tumor, Protocol Specific
Interventions: Drug: supersaturated calcium phosphate rinse;   Other: placebo;   Other: questionnaire administration;   Procedure: quality-of-life assessment
9 Recruiting Donor Atorvastatin Treatment for Preventing Severe Acute Graft-Versus-Host Disease in Patients Undergoing Myeloablative Peripheral Blood Stem Cell Transplantation
Conditions: Accelerated Phase Chronic Myelogenous Leukemia;   Adult Acute Lymphoblastic Leukemia in Remission;   Adult Acute Myeloid Leukemia in Remission;   Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities;   Adult Acute Myeloid Leukemia With Del(5q);   Adult Acute Myeloid Leukemia With Inv(16)(p13;q22);   Adult Acute Myeloid Leukemia With t(15;17)(q22;q12);   Adult Acute Myeloid Leukemia With t(16;16)(p13;q22);   Adult Acute Myeloid Leukemia With t(8;21)(q22;q22);   Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative;   Blastic Phase Chronic Myelogenous Leukemia;   Childhood Acute Lymphoblastic Leukemia in Remission;   Childhood Acute Myeloid Leukemia in Remission;   Childhood Burkitt Lymphoma;   Childhood Chronic Myelogenous Leukemia;   Childhood Diffuse Large Cell Lymphoma;   Childhood Immunoblastic Large Cell Lymphoma;   Childhood Myelodysplastic Syndromes;   Chronic Eosinophilic Leukemia;   Chronic Myelomonocytic Leukemia;   Chronic Neutrophilic Leukemia;   Chronic Phase Chronic Myelogenous Leukemia;   de Novo Myelodysplastic Syndromes;   Disseminated Neuroblastoma;   Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue;   High Risk Metastatic Gestational Trophoblastic Tumor;   Juvenile Myelomonocytic Leukemia;   Low Risk Metastatic Gestational Trophoblastic Tumor;   Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable;   Nodal Marginal Zone B-cell Lymphoma;   Noncontiguous Stage II Adult Burkitt Lymphoma;   Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma;   Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma;   Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma;   Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma;   Noncontiguous Stage II Adult Lymphoblastic Lymphoma;   Noncontiguous Stage II Grade 1 Follicular Lymphoma;   Noncontiguous Stage II Grade 2 Follicular Lymphoma;   Noncontiguous Stage II Grade 3 Follicular Lymphoma;   Noncontiguous Stage II Mantle Cell Lymphoma;   Noncontiguous Stage II Marginal Zone Lymphoma;   Noncontiguous Stage II Small Lymphocytic Lymphoma;   Plasma Cell Neoplasm;   Previously Treated Childhood Rhabdomyosarcoma;   Previously Treated Myelodysplastic Syndromes;   Primary Myelofibrosis;   Prolymphocytic Leukemia;   Recurrent Adult Acute Lymphoblastic Leukemia;   Recurrent Adult Acute Myeloid Leukemia;   Recurrent Adult Burkitt Lymphoma;   Recurrent Adult Diffuse Large Cell Lymphoma;   Recurrent Adult Diffuse Mixed Cell Lymphoma;   Recurrent Adult Diffuse Small Cleaved Cell Lymphoma;   Recurrent Adult Hodgkin Lymphoma;   Recurrent Adult Immunoblastic Large Cell Lymphoma;   Recurrent Adult Lymphoblastic Lymphoma;   Recurrent Childhood Acute Lymphoblastic Leukemia;   Recurrent Childhood Acute Myeloid Leukemia;   Recurrent Childhood Large Cell Lymphoma;   Recurrent Childhood Lymphoblastic Lymphoma;   Recurrent Childhood Rhabdomyosarcoma;   Recurrent Childhood Small Noncleaved Cell Lymphoma;   Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma;   Recurrent Gestational Trophoblastic Tumor;   Recurrent Grade 1 Follicular Lymphoma;   Recurrent Grade 2 Follicular Lymphoma;   Recurrent Grade 3 Follicular Lymphoma;   Recurrent Malignant Testicular Germ Cell Tumor;   Recurrent Mantle Cell Lymphoma;   Recurrent Marginal Zone Lymphoma;   Recurrent Mycosis Fungoides/Sezary Syndrome;   Recurrent Neuroblastoma;   Recurrent Ovarian Epithelial Cancer;   Recurrent Ovarian Germ Cell Tumor;   Recurrent Small Lymphocytic Lymphoma;   Recurrent Wilms Tumor and Other Childhood Kidney Tumors;   Recurrent/Refractory Childhood Hodgkin Lymphoma;   Refractory Chronic Lymphocytic Leukemia;   Refractory Hairy Cell Leukemia;   Refractory Multiple Myeloma;   Relapsing Chronic Myelogenous Leukemia;   Secondary Acute Myeloid Leukemia;   Secondary Myelodysplastic Syndromes;   Splenic Marginal Zone Lymphoma;   Stage I Multiple Myeloma;   Stage II Multiple Myeloma;   Stage II Ovarian Epithelial Cancer;   Stage II Ovarian Germ Cell Tumor;   Stage III Adult Burkitt Lymphoma;   Stage III Adult Diffuse Large Cell Lymphoma;   Stage III Adult Diffuse Mixed Cell Lymphoma;   Stage III Adult Diffuse Small Cleaved Cell Lymphoma;   Stage III Adult Hodgkin Lymphoma;   Stage III Adult Immunoblastic Large Cell Lymphoma;   Stage III Adult Lymphoblastic Lymphoma;   Stage III Childhood Hodgkin Lymphoma;   Stage III Childhood Large Cell Lymphoma;   Stage III Childhood Lymphoblastic Lymphoma;   Stage III Childhood Small Noncleaved Cell Lymphoma;   Stage III Chronic Lymphocytic Leukemia;   Stage III Grade 1 Follicular Lymphoma;   Stage III Grade 2 Follicular Lymphoma;   Stage III Grade 3 Follicular Lymphoma;   Stage III Malignant Testicular Germ Cell Tumor;   Stage III Mantle Cell Lymphoma;   Stage III Marginal Zone Lymphoma;   Stage III Multiple Myeloma;   Stage III Ovarian Epithelial Cancer;   Stage III Ovarian Germ Cell Tumor;   Stage III Small Lymphocytic Lymphoma;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer;   Stage IV Adult Burkitt Lymphoma;   Stage IV Adult Diffuse Large Cell Lymphoma;   Stage IV Adult Diffuse Mixed Cell Lymphoma;   Stage IV Adult Diffuse Small Cleaved Cell Lymphoma;   Stage IV Adult Hodgkin Lymphoma;   Stage IV Adult Immunoblastic Large Cell Lymphoma;   Stage IV Adult Lymphoblastic Lymphoma;   Stage IV Breast Cancer;   Stage IV Childhood Hodgkin Lymphoma;   Stage IV Childhood Large Cell Lymphoma;   Stage IV Childhood Lymphoblastic Lymphoma;   Stage IV Childhood Small Noncleaved Cell Lymphoma;   Stage IV Chronic Lymphocytic Leukemia;   Stage IV Grade 1 Follicular Lymphoma;   Stage IV Grade 2 Follicular Lymphoma;   Stage IV Grade 3 Follicular Lymphoma;   Stage IV Mantle Cell Lymphoma;   Stage IV Marginal Zone Lymphoma;   Stage IV Ovarian Epithelial Cancer;   Stage IV Ovarian Germ Cell Tumor;   Stage IV Small Lymphocytic Lymphoma
Interventions: Drug: atorvastatin calcium;   Procedure: peripheral blood stem cell transplantation;   Procedure: allogeneic hematopoietic stem cell transplantation
10 Recruiting Cause of Familial Testicular Cancer
Conditions: Testicular Neoplasms;   Germinoma
Intervention:
11 Unknown  Everolimus for Patients With Relapsed/Refractory Germ Cell Cancer
Conditions: Testicular Cancer;   Germ Cell Cancer
Intervention: Drug: Everolimus
12 Recruiting Everolimus in Refractory Testicular Germ Cell Cancer
Condition: Germ Cell Tumor
Intervention: Drug: Everolimus
13 Recruiting Palifosfamide in Treating Patients With Recurrent Germ Cell Tumors
Conditions: Adult Central Nervous System Germ Cell Tumor;   Adult Teratoma;   Malignant Extragonadal Germ Cell Tumor;   Malignant Extragonadal Non-Seminomatous Germ Cell Tumor;   Extragonadal Seminoma;   Recurrent Malignant Testicular Germ Cell Tumor;   Recurrent Ovarian Germ Cell Tumor;   Stage IV Extragonadal Non-Seminomatous Germ Cell Tumor;   Stage IV Extragonadal Seminoma;   Stage IV Ovarian Germ Cell Tumor
Intervention: Drug: palifosfamide
14 Recruiting Germ Cell Tumor and Testicular Tumor DNA Registry
Conditions: Germ Cell Tumor;   Testicular Tumor
Interventions: Behavioral: Questionnaires;   Other: sample of blood or saliva
15 Recruiting Shared Care Follow-up After Chemotherapy for Testicular Cancer
Condition: Testicular Cancer
Intervention:
16 Recruiting The Effect of Induction Technique on Postoperative Pain and Agitation
Conditions: Hernia, Inguinal;   Cryptorchidism
Interventions: Drug: Sevofluorane;   Drug: Propofol
17 Recruiting Defining the Genetic Basis for the Development of Primary Pigmented Nodular Adrenocortical Disease (PPNAD) and the Carney Complex
Conditions: Cushing's Syndrome;   Hereditary Neoplastic Syndrome;   Lentigo;   Neoplasm;   Testicular Neoplasm
Intervention:
18 Recruiting DNA Analysis in Samples From Younger Patients With Germ Cell Tumors and Their Parents or Siblings
Conditions: Childhood Malignant Ovarian Germ Cell Tumor;   Childhood Malignant Testicular Germ Cell Tumor;   Ovarian Choriocarcinoma;   Ovarian Embryonal Carcinoma;   Ovarian Mixed Germ Cell Tumor;   Ovarian Teratoma;   Ovarian Yolk Sac Tumor;   Testicular Choriocarcinoma;   Testicular Embryonal Carcinoma;   Testicular Seminoma;   Testicular Teratoma;   Testicular Yolk Sac Tumor
Interventions: Other: laboratory biomarker analysis;   Other: questionnaire administration
19 Unknown  Follow-up Evaluation Using CT Scans in Patients Who Have Been Treated For Metastatic Testicular Cancer
Condition: Testicular Germ Cell Tumor
Interventions: Other: biomarker analysis;   Procedure: computed tomography
20 Recruiting Taste, Smell and Chemotherapy (TASTY)
Condition: Testicular Cancer
Interventions: Procedure: Dexa scan;   Procedure: audiogram;   Procedure: measurement of heart rate variability and baroreflex sensitivity;   Procedure: Glucose tolerance assessment;   Dietary Supplement: oral nutrition supplements;   Behavioral: Two day food records;   Behavioral: Food Frequency Questionnaire

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years